I-FACTOR PEPTIDE ENHANCED BONE GRAFT
Device
Cerapedics, Inc.
Total Payments
$3.2M
Transactions
7,601
Doctors
2,195
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.1M | 2,184 | 863 |
| 2023 | $673,059 | 1,742 | 865 |
| 2022 | $988,561 | 1,923 | 768 |
| 2021 | $464,507 | 1,752 | 348 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.7M | 477 | 52.3% |
| Travel and Lodging | $496,175 | 1,011 | 15.4% |
| Food and Beverage | $414,293 | 4,456 | 12.9% |
| Unspecified | $292,424 | 71 | 9.1% |
| Honoraria | $127,788 | 96 | 4.0% |
| Charitable Contribution | $85,526 | 3 | 2.7% |
| Grant | $60,000 | 2 | 1.9% |
| Education | $56,371 | 1,474 | 1.8% |
| Entertainment | $1,734 | 11 | 0.1% |
Payments by Type
General
$2.9M
7,530 transactions
Research
$292,424
71 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Aspire Trial | Cerapedics Inc. | $292,424 | 0 |
Top Doctors Receiving Payments for I-FACTOR PEPTIDE ENHANCED BONE GRAFT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Inamullah Khan | — | Columbia, MO | $393,744 | 91 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $300,173 | 189 |
| , M.D., PH.D | Neurological Surgery | Altoona, PA | $202,271 | 98 |
| , MD | Orthopaedic Surgery of the Spine | Boston, MA | $125,177 | 99 |
| , MD | Neurological Surgery | New York, NY | $115,404 | 36 |
| , MD | Pediatric Orthopaedic Surgery | Columbus, OH | $101,762 | 72 |
| , M.D | Neurological Surgery | Boulder, CO | $87,829 | 78 |
| , MD | Student in an Organized Health Care Education/Training Program | Rochester, MN | $78,618 | 102 |
| , M.D | Orthopaedic Surgery of the Spine | Philadelphia, PA | $67,715 | 71 |
| , DPM | Foot & Ankle Surgery | Exton, PA | $63,086 | 18 |
| , D.O | Orthopaedic Surgery | Camp Hill, PA | $49,475 | 35 |
| , MD | Orthopaedic Surgery of the Spine | Aurora, CO | $43,546 | 46 |
| , M.D., PH.D | Orthopaedic Surgery | San Diego, CA | $36,903 | 21 |
| , M.D | Orthopaedic Surgery of the Spine | Columbia, MO | $35,133 | 40 |
| , M.D | Orthopaedic Surgery of the Spine | Los Angeles, CA | $33,485 | 30 |
| , M.D | Neurological Surgery | Baltimore, MD | $28,464 | 51 |
| , MD | Orthopaedic Surgery of the Spine | Rochester, MN | $28,139 | 23 |
| , MD | Orthopaedic Surgery | Port Saint Lucie, FL | $27,229 | 27 |
| , MD | Neurological Surgery | Houston, TX | $27,135 | 27 |
| , MD | Neurological Surgery | Saint Louis, MO | $26,581 | 12 |
| , M.D | Orthopaedic Surgery of the Spine | Cincinnati, OH | $23,507 | 14 |
| , MD | Neurological Surgery | Saint Louis, MO | $23,123 | 8 |
| , MD | Neurological Surgery | Charlottesville, VA | $22,496 | 16 |
| , M.D | Orthopaedic Surgery | Houston, TX | $21,214 | 12 |
| , M.D., F.A.C.S | Surgical Critical Care | Gainesville, FL | $15,798 | 9 |
Ad
Manufacturing Companies
- Cerapedics Inc. $2.8M
- Cerapedics, Inc. $464,507
Product Information
- Type Device
- Total Payments $3.2M
- Total Doctors 2,195
- Transactions 7,601
About I-FACTOR PEPTIDE ENHANCED BONE GRAFT
I-FACTOR PEPTIDE ENHANCED BONE GRAFT is a device associated with $3.2M in payments to 2,195 healthcare providers, recorded across 7,601 transactions in the CMS Open Payments database. The primary manufacturer is Cerapedics, Inc..
Payment data is available from 2021 to 2024. In 2024, $1.1M was paid across 2,184 transactions to 863 doctors.
The most common payment nature for I-FACTOR PEPTIDE ENHANCED BONE GRAFT is "Consulting Fee" ($1.7M, 52.3% of total).
I-FACTOR PEPTIDE ENHANCED BONE GRAFT is associated with 1 research study, including "Aspire Trial" ($292,424).